cOVID vaccine to be manufactured in Calgary; clinical trials have now begun
Sorenson said results from Providence's animal trials were promising, and on par with Pfizer and Moderna in terms of effectiveness
A group of healthy volunteers aged 18 to 65 have been divided into four groups of 15. Each of the three groups is receiving three different dose levels, while a fourth group gets a placebo.
It's a promising start, but the people behind the project worry that the federal government isn't doing enough to help with this potential home-grown solution.
"We are continuing to move forward we're continuing to build our own capacity but if engaging with the federal gov
